These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization. Harvala H; Nguyen D; Simmonds P; Lamikanra AA; Tsang HP; Otter A; Maes P; Webster M; Clarkson A; Kaloyirou F; Hopkins V; Laidlaw SM; Carroll M; Mora A; Griffiths A; MacLennan S; Estcourt L; Roberts DJ Transfusion; 2022 Jul; 62(7):1347-1354. PubMed ID: 35588314 [TBL] [Abstract][Full Text] [Related]
29. Vaccination of COVID-19 convalescent plasma donors increases binding and neutralizing antibodies against SARS-CoV-2 variants. Di Germanio C; Simmons G; Thorbrogger C; Martinelli R; Stone M; Gniadek T; Busch MP Transfusion; 2022 Mar; 62(3):563-569. PubMed ID: 35129839 [TBL] [Abstract][Full Text] [Related]
30. Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19. Franchini M; Del Fante C; Klersy C; Glingani C; Percivalle E; Baldanti F; Perotti C Semin Thromb Hemost; 2020 Oct; 46(7):804-806. PubMed ID: 32512588 [No Abstract] [Full Text] [Related]
31. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain. Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438 [TBL] [Abstract][Full Text] [Related]
32. Challenges of Convalescent Plasma Therapy on COVID-19. Zhao Q; He Y J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026 [No Abstract] [Full Text] [Related]
33. Antibodies, epicenter of SARS-CoV-2 immunology. Pecetta S; Pizza M; Sala C; Andreano E; Pileri P; Troisi M; Pantano E; Manganaro N; Rappuoli R Cell Death Differ; 2021 Feb; 28(2):821-824. PubMed ID: 33500559 [No Abstract] [Full Text] [Related]
34. Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations. Franchini M; Mengoli C; Ballotari A; Glingani C Transfus Clin Biol; 2022 May; 29(2):186-187. PubMed ID: 34690072 [No Abstract] [Full Text] [Related]
35. Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma. Nguyen D; Xiao J; Simmonds P; Lamikanra A; Odon V; Ratcliff J; Townsend A; Roberts DJ; Harvala H J Infect Dis; 2022 Mar; 225(6):971-976. PubMed ID: 34751775 [TBL] [Abstract][Full Text] [Related]
36. Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants. Strohl WR; Ku Z; An Z; Carroll SF; Keyt BA; Strohl LM BioDrugs; 2022 May; 36(3):231-323. PubMed ID: 35476216 [TBL] [Abstract][Full Text] [Related]
37. Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma. Franchini M; Mengoli C; Caruso B; Petilino R; Ballotari A; Glingani C Clin Chem Lab Med; 2022 Jan; 60(1):e4-e6. PubMed ID: 34472761 [No Abstract] [Full Text] [Related]
38. The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID-19. Liao M; Liao X; Yuan J; Zhou B; Liu Y; Jiang X; Zhang Z; Guo C; Zhang Y; Zhang S; Liu L; Zhang Z Clin Transl Med; 2021 Nov; 11(11):e571. PubMed ID: 34841732 [No Abstract] [Full Text] [Related]
39. Plasma therapy: a passive resistance against the deadliest. Hansda A; Biswas D; Bhatta A; Chakravorty N; Mukherjee G Hum Vaccin Immunother; 2022 Apr; 18(2):2006026. PubMed ID: 34886756 [TBL] [Abstract][Full Text] [Related]
40. Serum anti-Spike immunoglobulin G levels in random blood donors in Italy: High-titre convalescent plasma is easier than ever to procure. Focosi D; Meschi S; Coen S; Iorio MC; Franchini M; Lanza M; Maggi F Vox Sang; 2023 Sep; 118(9):794-797. PubMed ID: 37489640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]